Richard Friedman to Risk Factors
This is a "connection" page, showing publications Richard Friedman has written about Risk Factors.
Connection Strength
0.232
-
Clinical experience with novel oral anticoagulants for thromboprophylaxis after elective hip and knee arthroplasty. Arterioscler Thromb Vasc Biol. 2015 Apr; 35(4):771-8.
Score: 0.060
-
Complication rates after hip or knee arthroplasty in morbidly obese patients. Clin Orthop Relat Res. 2013 Oct; 471(10):3358-66.
Score: 0.053
-
Dabigatran versus enoxaparin for prevention of venous thromboembolism after hip or knee arthroplasty: a pooled analysis of three trials. Thromb Res. 2010 Sep; 126(3):175-82.
Score: 0.043
-
Rate of Improvement in Clinical Outcomes with Anatomic and Reverse Total Shoulder Arthroplasty. Bull Hosp Jt Dis (2013). 2015 Dec; 73 Suppl 1:S111-7.
Score: 0.016
-
Deep vein thrombosis (DVT) and pulmonary embolism (PE): awareness and prophylaxis practices reported by patients with cancer. Cancer Invest. 2015; 33(9):405-10.
Score: 0.015
-
Benefit-risk assessment of rivaroxaban versus enoxaparin for the prevention of venous thromboembolism after total hip or knee arthroplasty. Vasc Health Risk Manag. 2014; 10:157-67.
Score: 0.014
-
Dabigatran is effective with a favourable safety profile in normal and overweight patients undergoing major orthopaedic surgery: a pooled analysis. Thromb Res. 2012 Nov; 130(5):818-20.
Score: 0.013
-
Oral thrombin inhibitor dabigatran etexilate vs North American enoxaparin regimen for prevention of venous thromboembolism after knee arthroplasty surgery. J Arthroplasty. 2009 Jan; 24(1):1-9.
Score: 0.009
-
The incidence of malignant melanoma in the United States: issues as we approach the 21st century. J Am Acad Dermatol. 1996 May; 34(5 Pt 1):839-47.
Score: 0.004
-
Risk of cutaneous malignant melanoma in patients with 'classic' atypical-mole syndrome. A case-control study. Arch Dermatol. 1994 Aug; 130(8):993-8.
Score: 0.004